Skip to main content
. 2019 May 3;11(5):621. doi: 10.3390/cancers11050621
Hepatocellular carcinoma (HCC) transforming growth factor-β (TGF-β)
nonalcoholic fatty liver disease (NAFLD) reactive oxygen species (ROS)
hepatitis B virus (HBV) Receptor for activated C kinase1 (RACK1)
hepatitis C virus (HCV) Myeloid cell leukemia-1 (Mcl-1)
HBV X protein (HBx) Transforming acidic coiled-coil protein 3 (TACC3)
Aflatoxin B1 (AFB1) GATA transcription factor 5 (GATA5)
tumor necrosis factor-α (TNF-α) Level of Atonal homolog 8 (ATOH8)
interleukin 6 (IL-6) basic-helix-loop-helix (bHLH)
programmed death-ligand 1 (PD-L1) Zinc finger E-box binding Hox 1 (ZEB1)
programmed cell death 1 (PD-1) MYC-associated zinc finger protein (MAZ)
tumor-initiating stem-like cells (TICs) microRNAs (miRNAs)
mesenchymal transition (EMT) long non-coding RNAs (lncRNAs)
epithelial cell adhesion molecule (EpCAM) Long non-coding RNA activated by TGF-β (lncRNA-ATB)
octamer-binding transcription factor 4 (Oct4) intestine-specific homeobox transcription factor (ISX)
insulin-like growth factor (IGF) 2 aryl hydrocarbon receptor (AhR)
IGF 1 receptor (IGF1R) Toll-like receptor 4 (TLR4)
vascular endothelial growth factor (VEGF) Damage-associated molecular patterns (DAMPs)